(Q26859879)

language of work or name

1 reference

February 2013

1 reference

1 reference

29

1 reference

issue

2

1 reference

page(s)

165-73

1 reference

History of oncolytic viruses: genesis to genetic engineering

cites work

1 reference

https://api.crossref.org/works/10.1051%2FMEDSCI%2F2013292014

Natural and genetically engineered viral agents for oncolysis and gene therapy of human cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1051%2FMEDSCI%2F2013292014

Treatment of human cancer with mumps virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1051%2FMEDSCI%2F2013292014

Targeted inflammation during oncolytic virus therapy severely compromises tumor blood flow

21 January 2018

1 reference

https://api.crossref.org/works/10.1051%2FMEDSCI%2F2013292014

Cancer selective adenoviruses

21 January 2018

1 reference

https://api.crossref.org/works/10.1051%2FMEDSCI%2F2013292014

Exploiting tumor-specific defects in the interferon pathway with a previously unknown oncolytic virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1051%2FMEDSCI%2F2013292014

VSV strains with defects in their ability to shutdown innate immunity are potent systemic anti-cancer agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1051%2FMEDSCI%2F2013292014

Identification of genetically modified Maraba virus as an oncolytic rhabdovirus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1051%2FMEDSCI%2F2013292014

Rational strain selection and engineering creates a broad-spectrum, systemically effective oncolytic poxvirus, JX-963

21 January 2018

1 reference

https://api.crossref.org/works/10.1051%2FMEDSCI%2F2013292014

Potent systemic therapy of multiple myeloma utilizing oncolytic vesicular stomatitis virus coding for interferon-β.

21 January 2018

1 reference

https://api.crossref.org/works/10.1051%2FMEDSCI%2F2013292014

Enhancement of oncolytic properties of recombinant newcastle disease virus through antagonism of cellular innate immune responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1051%2FMEDSCI%2F2013292014

Enhancing poxvirus oncolytic effects through increased spread and immune evasion

21 January 2018

1 reference

https://api.crossref.org/works/10.1051%2FMEDSCI%2F2013292014

Effective gene-viral therapy of leukemia by a new fiber chimeric oncolytic adenovirus expressing TRAIL: in vitro and in vivo evaluation

21 January 2018

1 reference

https://api.crossref.org/works/10.1051%2FMEDSCI%2F2013292014

Lymphoma chemovirotherapy: CD20-targeted and convertase-armed measles virus can synergize with fludarabine

21 January 2018

1 reference

https://api.crossref.org/works/10.1051%2FMEDSCI%2F2013292014

Image-guided radiovirotherapy for multiple myeloma using a recombinant measles virus expressing the thyroidal sodium iodide symporter

21 January 2018

1 reference

https://api.crossref.org/works/10.1051%2FMEDSCI%2F2013292014

Systemic therapy of disseminated myeloma in passively immunized mice using measles virus-infected cell carriers

21 January 2018

1 reference

https://api.crossref.org/works/10.1051%2FMEDSCI%2F2013292014

Oncolytic and immunostimulatory efficacy of a targeted oncolytic poxvirus expressing human GM-CSF following intravenous administration in a rabbit tumor model

21 January 2018

1 reference

https://api.crossref.org/works/10.1051%2FMEDSCI%2F2013292014

An oncolytic adenovirus expressing granulocyte macrophage colony-stimulating factor shows improved specificity and efficacy for treating human solid tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1051%2FMEDSCI%2F2013292014

"Buy one get one free": armed viruses for the treatment of cancer cells and their microenvironment

21 January 2018

1 reference

https://api.crossref.org/works/10.1051%2FMEDSCI%2F2013292014

Neoadjuvant treatment of hepatic malignancy: an oncolytic herpes simplex virus expressing IL-12 effectively treats the parent tumor and protects against recurrence-after resection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1051%2FMEDSCI%2F2013292014

Enhanced therapeutic efficacy of IL-12, but not GM-CSF, expressing oncolytic herpes simplex virus for transgenic mouse derived prostate cancers.

21 January 2018

1 reference

https://api.crossref.org/works/10.1051%2FMEDSCI%2F2013292014

Engineered herpes simplex virus expressing IL-12 in the treatment of experimental murine brain tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1051%2FMEDSCI%2F2013292014

Therapeutic and tumor-specific immunity induced by combination of dendritic cells and oncolytic adenovirus expressing IL-12 and 4-1BBL.

21 January 2018

1 reference

https://api.crossref.org/works/10.1051%2FMEDSCI%2F2013292014

Triple gene-deleted oncolytic herpes simplex virus vector double-armed with interleukin 18 and soluble B7-1 constructed by bacterial artificial chromosome-mediated system

21 January 2018

1 reference

https://api.crossref.org/works/10.1051%2FMEDSCI%2F2013292014

Oncolytic herpes simplex virus armed with xenogeneic homologue of prostatic acid phosphatase enhances antitumor efficacy in prostate cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1051%2FMEDSCI%2F2013292014

Intelligent design: combination therapy with oncolytic viruses

21 January 2018

1 reference

https://api.crossref.org/works/10.1051%2FMEDSCI%2F2013292014

Synergistic interaction between oncolytic viruses augments tumor killing

21 January 2018

1 reference

https://api.crossref.org/works/10.1051%2FMEDSCI%2F2013292014

Oncolytic viruses and histone deacetylase inhibitors--a multi-pronged strategy to target tumor cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1051%2FMEDSCI%2F2013292014

Oncolytic virus therapy of multiple tumors in the brain requires suppression of innate and elicited antiviral responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1051%2FMEDSCI%2F2013292014

A high-throughput pharmacoviral approach identifies novel oncolytic virus sensitizers

21 January 2018

1 reference

https://api.crossref.org/works/10.1051%2FMEDSCI%2F2013292014

Identification of the ENT1 antagonists dipyridamole and dilazep as amplifiers of oncolytic herpes simplex virus-1 replication

21 January 2018

1 reference

https://api.crossref.org/works/10.1051%2FMEDSCI%2F2013292014

21 January 2018

Oncolytic virotherapy

1 reference

https://api.crossref.org/works/10.1051%2FMEDSCI%2F2013292014

Intravenous delivery of a multi-mechanistic cancer-targeted oncolytic poxvirus in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1051%2FMEDSCI%2F2013292014

[Measles virus: a future therapeutic agent in oncology?].

21 January 2018

1 reference

https://api.crossref.org/works/10.1051%2FMEDSCI%2F2013292014

10.1051/MEDSCI/2013292014

21 January 2018

Identifiers

DOI

0 references

Erudit article ID

2013292014

0 references

PubMed publication ID

23452603

1 reference